<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174965</url>
  </required_header>
  <id_info>
    <org_study_id>MiniHip</org_study_id>
    <nct_id>NCT02174965</nct_id>
  </id_info>
  <brief_title>Wear and Migration in the Corin Mini-Hip/Metafix and ECIMA Polyethylene</brief_title>
  <acronym>MiniHip</acronym>
  <official_title>RSA-measured in Vivo Wear, Migration and Micromotion in the Corin Mini-Hip/Metafix and ECIMA Polyethylene.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Corin</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oxford University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine whether the Mini Hip (Corin, U.K.)
      femoral component has a predictable and stable migration pattern (mean migration of the
      femoral component in three-dimensions,in mm) over a three year period, compared to a
      conventional cementless stem (Metafix, Corin, U.K.). The secondary objectives of this study
      are to determine whether the Trinity (Corin, U.K.) acetabular component has a predictable and
      stable migration pattern over a three year period and to measure the linear wear of femoral
      head into the ECIMA Highly Cross-linked polyethylene.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiostereometric Analysis (RSA) measured migration (mm)</measure>
    <time_frame>Measured pre-operatively (baseline) and at 3, 6, 12, 18, 24 and 36 months post-operatively</time_frame>
    <description>The images taken at each time point will be compared with the baseline to assess implant migration. Therefore the outcome is change in implant position measured using RSA.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dynamically Inducible Micromotion DIMM (mm)</measure>
    <time_frame>Measured at 6, 12, 24 and 36 months post-operatively</time_frame>
    <description>Using RSA this compares standard images with images taken in a single leg stance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant failure for femoral and acetabular components</measure>
    <time_frame>Observed at 3, 6, 12, 18, 24 and 36 months post-operatively</time_frame>
    <description>Follow up assessment will monitor for signs of implant failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Oxford Hip Score</measure>
    <time_frame>Measured pre-operatively (baseline) and at 3, 6, 12, 18, 24 and 36 months post-operatively</time_frame>
    <description>A PROM to assess patient benefit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Harris Hip Score</measure>
    <time_frame>Measured pre-operatively (baseline) and at 3, 6, 12, 18, 24 and 36 months post-operatively</time_frame>
    <description>A clinician recorded outcome score to assess functional improvement.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>DEXA Scan</measure>
    <time_frame>Pre-operatively (baseline) and at 12 months post-operatively</time_frame>
    <description>To monitor for peri-prosthetic changes in bone density following surgery</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>MiniHip (Corin U.K.)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MiniHip (Corin U.K.) femoral component</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metafix (Corin, U.K)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Metafix (Corin, U.K) conventional cementless stem</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MiniHip (Corin U.K.)</intervention_name>
    <description>MiniHip (Corin U.K.) femoral component</description>
    <arm_group_label>MiniHip (Corin U.K.)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Metafix (Corin, U.K)</intervention_name>
    <description>Metafix (Corin, U.K) conventional cementless stem</description>
    <arm_group_label>Metafix (Corin, U.K)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women and men between the ages of 18 and 65 years old.

          -  Scheduled to receive a hip replacement

          -  Willing and able to give informed consent for participation in the study.

          -  Diagnosed with hip osteoarthritis

          -  Able (in the investigators opinion) and willing to comply with all study requirements.

          -  Willing to allow his/her General Practitioner and consultant, if appropriate, to be
             notified of participation in the study

        Exclusion Criteria:

        The participants may not enter the study if ANY of the following apply:

          -  Inflammatory arthropathy, osteoporosis or deformities of the proximal femur.

          -  Significant comorbidities that would make follow up difficult or uncomfortable

          -  Any other significant disease or disorder which, in the opinion of the investigator,
             may either put the participant at risk due to participation in the study, may
             influence the result of the study, or the participants ability to participate in the
             study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sion Glyn-Jones, MA MBBS MRCS FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oxford</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Broomfield</last_name>
    <email>john.broomfield@ndorms.ox.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alice Harin</last_name>
    <email>alice.harin@ouh.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nuffield Orthopaedic Centre</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Broomfield</last_name>
      <email>john.broomfield@ndorms.ox.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2013</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>June 24, 2014</last_update_submitted>
  <last_update_submitted_qc>June 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

